Drug intelligence / Profile preview

smallpox vaccinia vaccine

Development stage
Unknown
Lead developer
Emergent BioSolutions
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Topical
01

Overview

Smallpox vaccinia vaccine is a **live viral vaccine** used for active immunization against smallpox and related orthopoxvirus exposure risk. It uses **vaccinia virus**, a poxvirus related to variola virus but less pathogenic in humans, to induce humoral and cellular immune responses that protect against smallpox. The term is **non-specific** because it can refer to multiple distinct products and generations, including replication-competent vaccinia vaccines such as ACAM2000 and older Dryvax, as well as replication-deficient Modified Vaccinia Ankara vaccines such as JYNNEOS, which differ in strain, manufacturing platform, administration, and safety profile. These vaccines have primarily been used for biodefense preparedness and vaccination of people at elevated occupational or exposure risk rather than for routine population-wide immunization.

Other names
smallpox vaccinevaccinia vaccinesmallpox vaccinia vaccine

Beyond the preview

Go deeper on smallpox vaccinia vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on smallpox vaccinia vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call